Market
CellCarta, Waters Corporation collaborate on companion diagnostics
CellCarta and Waters Corporation have formed a strategic partnership to develop companion diagnostics (CDx) and next-generation flow cytometry solutions for pharmaceutical and biotechnology customers. The collaboration combines CellCarta's diagnostic capabilities with Waters' analytical instrumentation expertise to advance CDx platforms and flow cytometry technology.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network